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Abstract
Background Brown seaweeds are known to be a rich source of fiber with the presence of several non-digestible polysaccha-
rides including laminarin, fucoidan and alginate. These individual polysaccharides have previously been shown to favorably 
alter the gut microbiota composition and activity albeit the effect of the collective brown seaweed fiber component on the 
microbiota remains to be determined.
Methods This study investigated the effect of a crude polysaccharide-rich extract obtained from Laminaria digitata (CE) 
and a depolymerized CE extract (DE) on the gut microbiota composition and metabolism using an in vitro fecal batch culture 
model though metagenomic compositional analysis using 16S rRNA FLX amplicon pyrosequencing and short-chain fatty 
acid (SCFA) analysis using GC-FID.
Results Selective culture analysis showed no significant changes in cultured lactobacilli or bifidobacteria between the CE or 
DE and the cellulose-negative control at any time point measured (0, 5, 10, 24, 36, 48 h). Following metagenomic analysis, 
the CE and DE significantly altered the relative abundance of several families including Lachnospiraceae and genera includ-
ing Streptococcus, Ruminococcus and Parabacteroides of human fecal bacterial populations in comparison to cellulose after 
24 h. The concentrations of acetic acid, propionic acid, butyric acid and total SCFA were significantly higher for both the CE 
and DE compared to cellulose after 10, 24, 36 and 48 h fermentation (p < 0.05). Furthermore, the acetate:propionate ratio 
was significantly reduced (p < 0.05) for both CD and DE following 24, 36 and 48 h fermentation.
Conclusion The microbiota-associated metabolic and compositional changes noted provide initial indication of putative ben-
eficial health benefits of L. digitata in vitro; however, research is needed to clarify if L. digitata-derived fiber can favorably 
alter the gut microbiota and confer health benefits in vivo.
Keywords Seaweeds · Macroalgae · Laminaria digitata · Dietary fiber · Prebiotic · Gut microbiota · Short-chain fatty 
acids · Metagenomics
Introduction
Macroalgae as a food resource remains a substantial com-
ponent of the human diet with over 2 million kg of edible 
seaweed harvested globally every year [1]. There is increas-
ing interest in the health benefits associated with seaweed 
consumption, particularly in relation to the reduced risk of 
age-associated chronic diseases in Japanese populations; 
where seaweed consumption has been estimated to be as 
high as 5.3 g/day [2]. The high fiber content of seaweed, 
up to 46 g/100 g semi-dry sample weight [3], has been sug-
gested to contribute to the health benefits associated with 
seaweed consumption [4].
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The health benefits of dietary fiber have been widely rec-
ognized, where a daily intake of 25 g/day and up to 38 g/
day has been recommended by the European Food Safety 
Authority and US Institute of Medicine, respectively [5, 6], 
owing to empirical evidence for dietary fiber in reducing the 
risk of obesity, type 2 diabetes, and coronary heart disease 
[7]. The mechanisms to support a role for fiber in health have 
been associated with its viscosity and fecal bulking proper-
ties which may impact the rate and nature of gastrointestinal 
digestion/absorption and transit time [8]. There is also con-
siderable evidence to support a possible role for fiber in pro-
moting health through its ability to modulate gut microbiota 
composition and metabolism [9]. The proposed benefits of 
fiber on the intestinal microbiota are associated with their 
uptake and utilization by putative health-promoting bacteria 
species and the subsequent cross-species metabolism of fer-
mentation by-products [10–13]. The short-chain fatty acid 
(SCFA) microbial metabolites are of particular interest, with 
suggestions that they can promote health through regula-
tion of gut hormone release, cholesterol synthesis/metabo-
lism, enhanced satiety as well as exerting anticancer and 
anti-inflammatory effects [14–16]. Each fiber source will 
exert different effects on the microbiota as the fermentation 
properties of non-digestible polysaccharides are strongly 
influenced by the monomer composition, type of bond, and 
degree of polymerization (DP) [9, 17].
The majority of research investigating the health ben-
efits associated with fiber and/or its fermentation properties 
have predominantly focused on cereal and vegetable derived 
fiber [18]. More recently, there is increasing interest in the 
putative health benefits that may be associated with the fer-
mentation of brown seaweed fiber owing to the presence 
of polysaccharides not typically present in high amounts in 
the human diet, including alginates (blocks of 1–4-linked 
β-mannuronate and α-guluronate glycosides), fucoidan 
(primarily made up of sulphated 1,2- 1,3- and 1,4-linked 
α-l-fucose) and laminarins (a 1–3-linked β-glucan back-
bone with short 1–6 β-linked side chains) [19–22]. A small 
number of studies have investigated the effects of the indi-
vidual polysaccharides derived from brown seaweed on the 
gut microbiota composition using both in vitro and in vivo 
methods [23–35]. These studies have provided initial indica-
tions of the potential fermentability of these brown seaweed 
fiber components by the human microbiota. Nevertheless, it 
must be noted that the fermentation and metabolism of each 
individual non-digestible polysaccharide are considerably 
influenced by the availability of other, potentially competing, 
polysaccharide substrates that may be present in the digesta. 
In summary, extrapolating the putative health benefits of 
seaweed fiber from the aforementioned studies which inves-
tigated singular polysaccharides is limited by the absence 
of simultaneous exposure to the numerous polysaccharides 
present in the seaweed. This study aimed to investigate the 
fermentation properties of a relatively crude fiber mixture 
derived from the brown seaweed, Laminaria digitata, in 
an attempt to determine the fermentation properties of the 
whole fiber component. This study specifically evaluated 
the effects of a crude polysaccharide-rich extract obtained 
from L. digitata, (CE), and a processed depolymerized CE 
(DE), both of which were previously subjected to a simu-
lated in vitro digestion, on the microbial composition and 
metabolic activity of the human gut microbiota, where fruc-
tooligosaccharides (FOS) and cellulose served as positive 
and negative controls, respectively, using an in vitro human 
colonic model.
Materials and methods
Harvesting of L. digitata
Laminaria digitata was harvested at Finavarra, County 
Clare (53.159294, − 9.100080), during low tide 
(12.30 p.m.–4.00 p.m.) one day in June 2012. Identification 
of macroalgae species was carried out on-site by a marine 
biologist (National University of Ireland, Galway). The sea-
weed was gathered by detaching the holdfast from the rock 
using a knife, placed in black refuse bags, and transferred 
within 6 h to storage at − 20 °C until processing.
Polysaccharide extraction
Crude seaweed powder production
The seaweed was washed with freshwater to remove sand 
and epiphytes and laid onto trays and blast frozen (Blast 
freezer, New-Avon). The frozen seaweed was freeze-dried 
(FD80, Cuddon Freeze Dry, New Zealand) and processed 
into a powder using a Waring blender (New Hartford, CT, 
USA) and stored in vacuum-packed bags at − 20 °C prior 
to extraction.
Hot acid extraction
Ground seaweed was suspended in 0.1 M HCl at a ratio of 
1:10 (w/v). The extractions were carried out by incubating 
in an orbital shaker (MaxQ 6000 Shaker; Thermo Fisher 
Scientific, Dublin, Ireland) at 70 °C at 175 rpm for three 
successive time periods of 3, 3 and 24 h. The extracts were 
filtered with a muslin bag with the extract removed after 
each period and fresh solvent added to the retentate. The 
three extract batches were collated and underwent further 
filtering with cotton and glass wool using a funnel, Buchner 
flask and vacuum pump. The filtrates were neutralized with 
the addition of 20 M NaOH and freeze-dried (FD80, Cuddon 
Freeze Dry, New Zealand).
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Purification and further processing of extract
Ethanol precipitation
The freeze-dried acid extract was dissolved in Milli-Q water 
(1:2 w/v). This solution was mixed with analytical-grade 
ethanol (1:5 v/v) before centrifugation at 8000g for 10 min. 
The supernatant was subsequently discarded and the pellet 
obtained was allowed to air dry overnight in a fume cabinet 
before blast freezing and freeze-dried (FD80, Cuddon Freeze 
Dry, New Zealand) to produce the crude extract (CE).
Soluble and insoluble dietary fiber analyses
Soluble dietary fiber (SDF) and insoluble dietary fiber 
(IDF) were measured according to AOAC 991.43, AACC 
32-07.01, NMKL 129, 2003 methods using the ANKOM 
Dietary Fiber analyser (Macedon NY, USA).
Depolymerization of extract
A sample of CE underwent a depolymerization step using 
a Fenton’s reaction. CE was dissolved in 0.04%  FeSO4 (1:5 
w/v) solution to which  H2O2 (30% puriss grade) was added 
(1:40 v/v). The flask was incubated in an orbital shaker 
(MaxQ 6000 Shaker; Thermo Fisher Scientific, Dublin, Ire-
land) for 45 min at 80 °C and 175 rpm. The solution was 
then blast frozen and freeze-dried (FD80, Cuddon Freeze 
Dry, New Zealand) to produce the depolymerized CE extract 
(DE).
Simulated human gastrointestinal digestion
Prior to carrying out the in vitro digestion both the CE and 
DE underwent size-exclusion dialysis using dialysis tub-
ing with a molecular weight cutoff of 1 kDa (Standard RC 
dialysis tubing, Spectrum labs, Rancho Dominguez, USA). 
For this, the extracts were dissolved in Milli-Q water (1:1 
w/v) and placed within the dialysis tubing. The tubes were 
closed with clips and placed in 10 L of Milli-Q water and 
incubated in an orbital shaker (MaxQ 6000 Shaker; Thermo 
Fisher Scientific, Dublin, Ireland) at 25 °C, 50 rpm for 72 h. 
The water was changed every 24 h throughout the dialysis. 
The dialysate was discarded and the remaining extract was 
freeze-dried (FD80, Cuddon Freeze Dry, New Zealand). 
60 g of each sample obtained (> 1 kDa CE and DE, and cel-
lulose) was suspended in 180 mL of Milli-Q water (1:4 w/v) 
and added to a 500-mL Erlenmeyer flask to which a 6.25 mL 
solution of  CaCl2 (1 mM pH 7) with 20 mg of dissolved 
α-amylase had been added. The solutions were incubated 
in an orbital shaker (MaxQ 6000 Shaker; Thermo Fisher 
Scientific, Dublin, Ireland) at 150 rpm at 37 °C for 30 min. 
On completion of the incubation, the solutions were adjusted 
to pH 2 with concentrated HCl (37% puriss, 12.06 M). A 
pepsin solution of (2.7 g pepsin in 125 mL of 0.1 M HCl) 
was then added to each sample and the sample solutions 
were incubated in an orbital shaker (MaxQ 6000 Shaker) at 
37 °C 150 rpm for 2 h. The solutions were neutralized with 
1 M NaOH and 125 mL of 0.5 M  NaHCO3 followed by the 
addition of 560 mg pancreatin and 3.5 g bile extract. The 
solutions were adjusted to pH 7 with either the addition of 
1 M HCl or 1 M NaOH and further incubated in an orbital 
shaker (MaxQ 6000 Shaker) at 37 °C, 150 rpm for 3 h. The 
sample solutions (CE, DE and Cellulose) were subsequently 
transferred into 1-kDa dialysis tubing (Standard RC dialysis 
tubing, Spectrum labs) and placed in Milli-Q water for 72 h 
with the dialysate replaced every 24 h with fresh Milli-Q 
water. The solutions were then blast frozen and freeze-dried 
(FD80, Cuddon Freeze Dry, New Zealand) and stored at 
− 20 °C until use.
The controls used in the in vitro study were fructooli-
gosaccharides (FOS) and cellulose. FOS was selected as a 
positive control as it is a prebiotic fiber, while cellulose was 
chosen as a negative control as it is poorly fermented. The 
FOS solution did not undergo the in vitro digestion process 
as it is known to be resistant to digestion and would not be 
retained by the 1-kDa-molecular weight-cutoff dialysis tub-
ing. To account for any components which may result from 
the in vitro digestion procedure, an in vitro digestion was 
carried out without any substrate and the resulting freeze-
dried material was added to FOS in the correct ratio.
Fecal fermentations
Basal growth media
The basal growth medium used was similar to Fooks and 
Gibson [36] [2 g of peptone water (Oxoid thermos Fischer 
scientific, Renfrew, UK), 2 g of yeast extract (Oxoid ther-
mos Fischer scientific, Renfrew, UK), 0.1 g NaCl, 0.04 g of 
 K2HPO4, 0.04 g of  KH2PO4, 0.01 g of  CaCl2·6H20, 0.01 g 
of  MgSO4·7H20, 0.2 g of  NaHCO3, 2 mL of Tween-80 
(Sigma-Aldrich, St Louis, USA), 0.05 g of Hemin (Sigma-
Aldrich, St Louis, USA) dissolved in 0.5 mL of 1 M NaOH, 
10 µL of vitamin K dissolved in 200 µL of ethanol, 0.5 g of 
cysteine–HCl (Sigma-Aldrich, St Louis, USA), 0.5 g bile 
salts powder (Oxoid thermos Fischer scientific, Renfrew, 
UK)]. The pH of the media was reduced to 6.8 by the addi-
tion of 1 M HCl, autoclaved, and allowed to cool to 37 °C 
before use in the experiments.
Fecal sample collection and processing
Fecal fermentation experiments were carried out in triplicate 
on 3 different days. Freshly voided fecal samples from three 
healthy donors (Male, Caucasian Aged 18–32) were obtained 
 European Journal of Nutrition
1 3
within 1 h prior to the beginning of each experiment. A 20 g 
portion of fecal sample of each donor was collected in a 
Stomacher strainer bag (Seward Limited, Worthington, UK) 
to which 240 mL of autoclaved maximum recovery diluent 
(MRD, Oxoid Ltd, Hampshire, UK) cysteine–HCl solution 
was added. The mixture was homogenized using Seward 
Stomacher 400 circulator machine (Seward Limited, Wor-
thington, UK) at a normal speed for 1 min.
Fermentation vessel setup and sampling
The fermentations were carried out in two Multifors units 
(four vessels in total; Infors, Bottmingen, Switzerland) with 
160 mL of basal growth medium added to each vessel. First, 
the vessels were purged with filtered nitrogen gas for 2 h 
prior to the addition of the fecal slurry and for the duration 
of the experiment. After purging, 2 g of the extracts and con-
trols (2%) were subsequently added to their respective fer-
mentation vessel. The vessels were maintained at 37 °C and 
pH 6.8 with stirrers set at 100 rpm. A 40 mL sample of fecal 
slurry was immediately injected into each vessel. Within 
2 min following the addition of fecal slurry, a 13 mL aliquot 
was removed from each vessel for analysis to represent a 
baseline (T0), with further samples collected at 5, 10, 24, 36 
and 48 h. From each 13 mL sample collected, 2 × 1 mL ali-
quots were immediately used for culture-dependent bacterial 
enumeration. Also, a 5 mL sample was spun at 15,000 rpm 
for 5 min, and a total of 3 × 1 mL aliquots of supernatant 
were removed and stored at − 80 °C for future short-chain 
fatty acid (SCFA) analysis. For culture-independent PCR-
based GM analysis, 2 × 1 mL from each sample were ali-
quoted into microtubes and centrifuged at 15,000 rpm, with 
the supernatant discarded and pellets stored for pyrose-
quencing and stored at − 80 °C until analysis.
Enumeration, isolation and identification 
of Bifidobacteria and Lactobacillus species
Sample dilution
A 1 mL aliquot of the fermenter slurry sample was added 
to 9 mL of sterile MRD (Oxoid Ltd). A serial dilution was 
carried out by removing 1 mL from the previous tube and 
adding to the next 9 mL of MRD for a total of seven serial 
dilutions in duplicate.
The dilutions of the samples were then inoculated in 
duplicate onto selective agars, i.e., Lactobacillus selec-
tive (LBS) agar (Difco Becton Dickinson, Franklin Lakes, 
USA) supplemented with acetic acid (32 mM) and MRS agar 
(Oxoid thermos Fischer scientific, Renfrew, UK) with added 
0.2 g of l-cysteine–HCl and 100 × 200-µg mupirocin disks 
(Oxoid thermos Fischer scientific, Renfrew, UK). Inoculated 
LBS plates were incubated in an anaerobic cabinet at 37 °C 
for 120 h while MRS plates were incubated for 72 h before 
enumerating colonies on a SC6 plus Colony Counter (Stu-
art equipment, Stone, UK); for confirmation of species, five 
colonies from each plate were randomly selected and Gram 
stained.
Analysis of short‑chain fatty acids
Internal standard and external standard curve generation
As an internal standard, 2-ethyl butyric acid was added to 
both samples and standard curve solution at 1 mM. The 
seven SCFAs (acetic acid, propionic acid, iso-butyric acid, 
butyric acid, valeric acid, iso-valeric acid and hexanoic 
acid at 0.1 mM, 0.5 mM, 1 mM, 2 mM, 4 mM, 8 mM and 
10 mM) were used to generate a standard curve. Additional 
2 mM SCFA standard vials were used to check for reproduc-
ibility. A standard curve and five repeat injections of 2 mM 
SCFA were carried out prior to analysis.
Sample processing
A 200 µL sample of fermenter slurry supernatant was added 
to a 1.5-mL microtube along with 700 µL of Milli-Q water 
and 100 µL of 10 mM of 2-ethyl butyric acid. The samples 
were spun at 5,000 rpm and the supernatants were trans-
ferred to a 1.5-mL glass vial (Agilent Technologies, Santa 
Clara, USA).
GC-FID analysis
The concentration of SCFA was determined by gas chro-
matography flame ionization detection (GC-FID) using a 
Varian 3500 GC system, fitted with a TRB-FFAP column 
(30 m × 0.32 mm × 0.50 µm; Teknokroma, Barcelona, Spain) 
and a flame ionization detector. Helium was supplied as the 
carrier gas at an initial flow rate of 1.3 mL/min. The ini-
tial oven temperature was 100 °C, and was maintained for 
0.5 min, and then raised to 180 °C at 8 °C/min and held for 
1.0 min, before being increased to 200 °C at 20 °C/min, 
and finally held at 200 °C for 5.0 min. The temperatures 
of the detector and the injection port were set at 250 °C 
and 240 °C, respectively. The injected sample volume was 
0.5 µL. Peaks were integrated using Varian Star Chromatog-
raphy Workstation version 6.0 software.
454 Pyrosequencing
DNA extraction
Total microbial DNA was extracted from pellets of 1 mL of 
fermenter slurry using a MO BIO PowerFecal DNA isolation 
kit (Mo Bio, Carlsbad, USA) according to the manufacturer’s 
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instructions. To ensure complete lysis of bacterial cells, an 
additional heating step was carried out at 90 °C for 10 min 
prior to the bead beating step. The extracted DNA was quan-
tified in triplicate using a Nanodrop 3300 spectrophotometer 
(Thermo Scientific, Ireland) and stored at − 80 °C for future 
PCR amplification of the V4 amplicon.
Generation of 16S rDNA amplicons
PCR amplification of the V4 region was carried out using 
the KAPA3G Plant PCR kit (Kapa Biosystems, USA). 
Amplicons of the V4 region were generated by employing 
one forward, i.e., F1 (5′ AYT GGG YDTAAAGNG), and a 
mix of four reverse primers, i.e., R1 (5′ TAC CRG GGTHTCT 
AAT CC), R2 (5′ TAC CAG AGT ATC TAA TTC ), R3 (5′ 
CTACDSRGGTMTCT AAT C) and R4 (5′ TACNVGGG 
TAT CTA ATC ). In addition, the F1 contained an A adaptor 
sequence along with a distinct multiple identifier (MID) for 
each sample, while the R primers contained a B adaptor. The 
PCRs were carried out on a G-storm PCR machine under the 
following conditions: heated lid 110 °C, 95 °C for 10 min 
followed by 47 cycles of 95 °C for 20 s, 55 °C for 15 s and 
72 °C for 15 s followed by a 1 min at 72 °C after which the 
samples were held at 4 °C. The PCRs had a final volume 
of 50 µL and consisted of 25 µL of KAPA3G Plant PCR 
buffer, 0.4 µL of KAPA3G plant DNA polymerase, 1 µL of 
F1 primer (0.15 µM), 1 µL of the R1–4 primers (0.15 µM), 
1 µL of MgCl2 (to give a final concentration of 2 mM), ster-
ile PCR-grade water and 2.5 µL template DNA. PCR prod-
ucts were analyzed by agarose gel electrophoresis (1.5% in 
1× TBE buffer + 2 µL of Midori Green Advance DNA stain 
(Nippon Genetics)) loading 5 µL of PCR product with 2 µL 
of Bioline DNA loading buffer, blue. The remaining PCR 
product (45 µL) of each sample was cleaned using Agent-
court AMPure XP kit (Beckman Coulter Genomics, UK) as 
per the manufacturer’s protocol. The cleaned PCR products 
were eluted in 40 µL of solution C6 from the PowerFecal 
kit. The pooled sample underwent further cleaning using the 
AMPure XP kit and then quantified again with the Quant-
iT Picogreen kit. Emulsion-based clonal amplification was 
carried out before sequencing on a Genome Sequencer FLX 
platform (Roche Diagnostics Ltd, West Sussex, UK) accord-
ing to the manufacturer’s protocols. Sequencing was carried 
out at the Teagasc Moorepark Sequencing facility.
Bioinformatics analysis
Quality trimming of raw sequences was carried out using the 
QIIME program suite [39]. A minimum quality score of 25 
with sequence length of 150 bp was employed and any reads 
below these levels were discarded. Taxonomy was assigned 
using BLAST [37] referenced against the SILVA SSURef 
database (version 111) [38] and OTU alignment was carried 
using PyNAST Phylogenetic tree [39]. Alpha diversity indi-
ces were calculated using QIIME.
Statistical analysis
The statistical analysis was carried out on SPSS v18. The 
independent t test was employed to assess for statistically 
significant differences between groups, with p < 0.05 consid-
ered significant. The Benjamini–Hochberg false discovery 
rate procedure was applied to sequencing data with Q set 
at 20%.
Results
Dietary fibre analysis
The pre-simulated digested CE was found to contain 60% 
soluble dietary fiber and 0.5% insoluble dietary fiber.
Effects on bacterial composition as assessed by 454 
pyrosequencing
All treatment vessels (Cellulose, FOS, CE and DE) at base-
line (0 h) had similar proportions of phyla with Firmicutes 
the most abundant (69.67–75.881%) followed by Bacteroi-
detes (19.257–26.358%), Proteobacteria (2.881–3.449%) and 
Actinobacteria (0.873–1.499%) (Fig. 1). Other Phyla such as 
Cyanobacteria, Fibrobacteres, Fusobacteria, Lentisphaerae, 
Tenericutes, Verrucomicrobia, RF3 and bacteria unassigned 
to phyla (no blast hit) were lower in abundance. Figures 1, 
2 and 3 show a graphical representation of the taxa at the 
Phylum, Family and Genus levels at time 0 and after 24 h 
of fermentation with the test substrates (Fig. 1—Phylum; 
Fig. 2—Family; Fig. 3—Genus).
There were no significant differences between any test 
compounds and cellulose for the alpha diversity indices 
Chao1, Simpson, Shannon, phylogenetic diversity and num-
ber of observed species after 24 h (Fig. 4). There were no 
significant effects of any test compounds on Firmicutes to 
Bacteroidetes ratios after 24 h of fermentation (Fig. 4).
Crude extract (CE) (Table 1)
The Phyla Fibrobacteres was significantly reduced in CE-
treated vessels in comparison to cellulose-treated control 
vessels (p = 0.026, q = 0.018) (see Table 1). At the fam-
ily level, Porphyromonadaceae (p = 0.043, q = 0.014) and 
Lachnospiraceae (p = 0.015, q = 0.004) were significantly 
increased compared to cellulose. Porphyromonadaceae 
was the fourth most dominant bacterial family after 24 h 
of CE treatment as opposed to the seventh in cellulose-
treated vessels. In contrast, Fibrobacteraceae (p = 0.026, 
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Fig. 1  Mean relative abun-
dances of the five most 
abundant bacterial phyla of 
cellulose (Cell), fructooligo-
saccharides (FOS), Laminaria 
digitata crude polysaccharide-
rich extract (CE)- and Lami-
naria digitata-depolymerized 
polysaccharide-rich extract 
(DE) (1%)-treated fecal fermen-
tation vessels (n = 3) at 0 and 
24 h. Bacterial composition was 
assessed by 16S rDNA sequenc-
ing using 454 FLX technology 
and bacteria were assigned 
to their Phyla. The remaining 
Phyla were combined and repre-
sented within the group “Other”
Fig. 2  Mean relative abun-
dances of bacterial families of 
cellulose (Cell), fructooligo-
saccharides (FOS), Laminaria 
digitata crude polysaccharide-
rich extract (CE)- and Lami-
naria digitata-depolymerized 
polysaccharide-rich extract 
(DE) (1%)-treated fecal fermen-
tation vessels (n = 3) at 0 and 
24 h. Bacterial composition was 
assessed by 16S rDNA sequenc-
ing using 454 FLX technology 
and bacteria were assigned 
to their family. The figure 
represents the 15 most abundant 
families and any remaining 
families were combined and 
represented as other
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q = 0.01) and Streptococcaceae (p = 0.025, q = 0.007) were 
both reduced with CE treatment (see Table 1).
The increases in Porphyromonadaceae could be 
attributed to the stimulation of Parabacteroides species 
which increased significantly compared to control vessels 
(+ 4.754% vs. + 0.805%; p = 0.005, q = 0.003) (Table 1). 
There was a modest but significant increase in an uncul-
tured genera belonging to the B38 Proteobacteria line-
age (p = 0.045, q = 0.008), and also an increase in Dial-
ister species compared to cellulose-treated vessels was 
noted (p = 0.005, q = 0.001). Ruminococcus (p = 0.027, 
q = 0.007), Streptococcus (p = 0.022, q = 0.004) and Fibro-
bacter (p = 0.026, q = 0.005) species were all reduced 
after 24 h of fermentation of CE compared to cellulose-
treated vessels. There was no significant increase of any 
Lachnospiraceae genera, suggesting that the increases in 
this family occurred division wide.
Depolymerized extract (DE) (Table 2)
In common with CE extract, DE extract had a significant 
effect on the relative abundance of the genus Parabac-
teroides (p = 0.017), with DE treatment significantly 
increasing the relative abundance compared to cellulose 
(Table 2). DE treatment also had an effect on several 
families and genera within the Clostridiales order. The 
relative abundance of the Lachnospiraceae family was 
significantly higher after 24 h of fermentation when com-
pared to cellulose (p = 0.039, q = 0.007) and within this 
family there were significant increases in an uncharacter-
ized bacterium with DE treatment compared to cellulose 
Fig. 3  Mean relative abun-
dances of bacterial genera of 
cellulose (Cell), fructooligo-
saccharides (FOS), Laminaria 
digitata crude polysaccharide-
rich extract (CE)- and Lami-
naria digitata-depolymerized 
polysaccharide-rich extract 
(DE) (1%)-treated fecal fermen-
tation vessels (n = 3) at 0 and 
24 h. Bacterial composition was 
assessed by 16S rDNA sequenc-
ing using 454 FLX technology 
and bacteria were assigned to 
their genera. The figure repre-
sented the 15 most abundant 
genera and any remaining 
genera were combined and 
represented as other
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(p = 0.003, q = 0.001), although this was a less abundant 
genus that was not detected at 0 h in the cellulose vessel. 
A significant decrease in the relative abundance of the 
Peptostreptococcaceae Incertae Sedis family was observed 
with DE treatment. It should be noted that the relative 
Fig. 4  Mean alpha diversity indices and firmicutes:bacteroidetes 
ratios of cellulose (Cell), fructooligosaccharides (FOS), Laminaria 
digitata crude polysaccharide-rich extract (CE) and Laminaria dig-
itata-depolymerized polysaccharide-rich extract (DE) (1%)-treated 
fecal fermentation vessels (n = 3) after 24  h. Bacterial composition 
was assessed by 16S rDNA sequencing using 454 FLX technology 
and alpha diversity indices were calculated using QIIME
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abundances of the Peptostreptococcaceae Incertae Sedis 
family were statistically different at 0 h between DE and 
cellulose. As with the CE treatment, the relative abun-
dance of Dialister was significantly higher with DE treat-
ment compared to cellulose (p = 0.008, q = 0.003). The 
relative abundance of the Alcaligenaceae family belong-
ing to the Proteobacteria Phyla was significantly reduced 
compared to cellulose (p = 0.03, q = 0.004).
Fructooligosaccharides (Table 3)
FOS-fermented vessels had significantly lower proportions 
of Proteobacteria (p = 0.043, q = 0.018), with significantly 
lower representations of Alcaligenaceae (p = 0.01, q = 0.007) 
compared to cellulose. The reduction in Alcaligenaceae abun-
dance was mostly owing to reductions in the relative abun-
dance of Sutterella (p = 0.03, q = 0.009) compared to cellulose. 
There was a significant reduction in the relative abundance 
Table 1  Significant differences induced by crude polysaccharide-rich extract (CE) treatment on bacterial Phyla, Families and Genera
An overview of the significant changes in the relative abundance of the Phyla, Family and Genus (as determined by 454 pyrosequencing of the 
16S rDNA region) of the batch culture fermentate following a 24-h incubation with 1% (w/v) CE or cellulose under anaerobic conditions at 
37 °C. Significant differences of delta change values (∆) (difference 0 and 24 h) between CE and cellulose were determined using independent t 
tests (n = 3). Data presented are mean (SEM)
0 h 24 h ∆ Effect P
Cellulose (%) CE (%) Cellulose (%) CE (%) Cellulose CE
Phylum
 Fibrobacteres 0 (0) 0.009 (0.006) 0.04 (0.01) 0.012 (0.009) + 0.04 (0.005) + 0.003 (0.005) ↓ 0.026
Family
 Porphyromonadaceae 1.305 (0.176) 1.232 (0.175) 2.856 (0.703) 5.941 (0.546) + 1.551 (0.813) + 4.709 (0.713) ↑ 0.043
 Fibrobacteraceae 0 (0) 0.009 (0.006) 0.04 (0.01) 0.012 (0.009) + 0.04 (0.005) + 0.003 (0.005) ↓ 0.026
 Streptococcaceae 0.067 (0.043) 0.06 (0.004) 0.097 (0.056) 0.028 (0.016) + 0.03 (0.014) − 0.033 (0.012) ↓ 0.025
 Lachnospiraceae 32.303 (2.438) 32.55 (1.878) 16.718 (0.458) 26.182 (2.781) − 15.585 (1.992) − 6.368 (1.03) ↑ 0.015
Genus
 Parabacteroides 0.488 (0.152) 0.511 (0.05) 1.293 (0.35) 5.085 (0.674) + 0.805 (0.255) + 4.574 (0.633) ↑ 0.005
 Fibrobacter 0 (0) 0.009 (0.006) 0.04 (0.01) 0.012 (0.009) + 0.04 (0.005) + 0.003 (0.005) ↓ 0.026
 Streptococcus 0.06 (0.041) 0.06 (0.004) 0.097 (0.056) 0.028 (0.016) + 0.037 (0.015) − 0.033 (0.012) ↓ 0.022
 Ruminococcus 2.235 (0.983) 2.058 (0.524) 2.204 (1.291) 0.675 (0.377) − 0.032 (0.369) − 1.383 (0.148) ↓ 0.027
 Dialister 0.589 (0.107) 0.504 (0.169) 0.132 (0.084) 0.463 (0.136) − 0.457 (0.037) − 0.042 (0.062) ↑ 0.005
 γ B38UC 0.019 (0.009) 0.007 (0.007) 0.029 (0.01) 0.041 (0.003) + 0.01 (0.008) + 0.034 (0.004) ↑ 0.045
Table 2  Significant differences induced by depolymerized crude polysaccharide-rich extract (DE) on bacterial Phyla, Families and Genera
An overview of the significant changes in the relative abundance of the Phyla, Family and Genus (as determined by 454 pyrosequencing of the 
16S rDNA region) of the batch culture fermentate following a 24-h incubation with 1% (w/v) DE or cellulose under anaerobic conditions at 
37 °C. Significant differences of delta change values (∆) (difference 0 and 24 h) between DE and cellulose were determined using independent t 
tests (n = 3). Data presented are mean (SEM)
0 h 24 h ∆ Effect P
Cellulose (%) DE (%) Cellulose (%) DE (%) Cellulose DE
Phylum
 Actinobacteria 1.499 (0.299) 0.873 (0.218) 1.955 (0.284) 0.607 (0.13) + 0.456 (0.068) − 0.266 (0.171) ↓ 0.017
Family
 Lachnospiraceae 32.303 (2.438) 30.968 (1.478) 16.718 (0.458) 25.724 (3.06) − 15.585 (1.992) − 5.244 (2.791) ↑ 0.039
 Alcaligenaceae 0.636 (0.088) 1.071 (0.142) 6.444 (0.569) 3.864 (0.54) + 5.807 (2.793) + 2.793 (0.682) ↓ 0.030
Genus
 Parabacteroides 0.488 (0.15) 0.618 (0.206) 1.293 (0.35) 5.64 (1.234) + 0.805 (0.255) + 5.022 (1.039) ↑ 0.017
 Lachnospiraceae uc. 0 (0) 0.007 (0.003) 0.003 (0.003) 0.046 (0.003) + 0.003 (0.003) + 0.039 (0.005) ↑ 0.003
 Peptostreptococcaceae IS 0.846 (0.048) 1.299 (0.074) 0.32 (0.085) 0.244 (0.074) − 0.526 (0.051) − 1.056 (0.147) ↓ 0.027
 Dialister 0.589 (1.234) 0.418 (0.107) 0.132 (0.084) 0.277 (0.104) − 0.47 (0.037) − 0.141 (0.054) ↑ 0.008
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of the gamma Proteobacteria genus Cronobacter (p = 0.019, 
q = 0.004). FOS fermentation significantly decreased the 
relative abundance of two Bacteroidetes genera belonging to 
the Porphyromonadaceae family, Butyricimonas (p = 0.03, 
q = 0.008) and Parabacteroides (p = 0.023, q = 0.007). Within 
the Firmicutes phylum, FOS treatment resulted in a signifi-
cant reduction in Streptococcus (p = 0.023, q = 0.005), Chris-
tensenella (p = 0.033, q = 0.01) and Flavonifractor (p = 0.047, 
q = 0.012) and an increase in the relative abundance of Lach-
nospiraceae (p = 0.009, q = 0.004) and a poorly understood 
family (p = 0.032, q = 0.014) and genus (p = 0.016, q = 0.003) 
belonging to the Clostridiales Family XIII, when compared 
to cellulose.
Effects on culture‑dependent Lactobacillus 
and Bifidobacteria populations
Neither CE nor DE stimulated cultivable Lactobacillus or Bifi-
dobacteria species numbers at any time point. FOS was found 
to significantly (p = 0.044) increase cultivable Bifidobacteria 
populations after 10 h compared to cellulose control.
Effects on short‑chain fatty acid production
Crude extract (CE) (Table 4)
Within 5 h of fermentation of the CE, propionic acid con-
centrations were significantly increased (p = 0.003), and 
remained significantly higher over all subsequent time 
points in comparison to the cellulose control. Propionic 
acid concentrations in the CE-treated vessels were simi-
lar to that of the FOS-treated vessels for all time points 
assessed. After 10  h of CE fermentation, acetic acid 
(p = 0.001), butyric acid (p = 0.031), and total SCFA 
(p = 0.002) concentrations were also significantly higher 
than cellulose. Concentrations of acetic acid, butyric acid, 
and total SCFA were significantly higher with CE treat-
ment compared to cellulose for all subsequent time points. 
The acetate:propionate ratio was significantly lower than 
the cellulose control following 24, 36 and 48 h of fermen-
tation (p < 0.05) (Fig. 5). There were no significant differ-
ences in the concentration of valeric acid, hexanoic acid, 
the individual branched-chain SCFAs iso-butyric acid and 
Table 3  Significant differences induced by FOS treatment on bacterial Phyla, Families and Genera
An overview of the significant changes in the relative abundance of the Phyla, Family and Genus (as determined by 454 pyrosequencing of the 
16S rDNA region) of the batch culture fermentate following a 24-h incubation with 1% (w/v) FOS or cellulose under anaerobic conditions at 
37 °C. Significant differences of delta change values (∆) (difference 0 and 24 h) between FOS and cellulose were determined using independent 
t tests (n = 3). Data presented are mean (SEM)
0 h 24 h ∆ Effect P 
Cellulose (%) FOS (%) Cellulose (%) FOS (%) Cellulose FOS
Phylum
 Proteobacteria 3.11 (0.312) 2.881 (0.279) 11.082 (1.226) 3.968 (1.628) + 7.972 (1.368) + 1.087 (1.904) ↓ 0.043
Family
 Streptococcaceae 0.067 (0.043) 0.129 (0.045) 0.097 (0.056) 0.003 (0.003) + 0.03 (0.014) − 0.126 (0.043) ↓ 0.025
 Clostridium XIII IS 0.032 (0.013) 0.011 (0.011) 0.069 (0.067) 0.227 (0.063) + 0.037 (0.016) + 0.216 (0.053) ↑ 0.032
 Lachnospiraceae 32.303 (2.438) 27.771 (0.886) 16.718 (0.485) 21.909 (1.271) − 15.585 (1.99) − 5.862 (0.387) ↑ 0.009
 Alcaligenaceae 0.636 (0.088) 0.988 (0.262) 6.444 (0.569) 1.959 (0.612) + 5.807 (0.612) + 0.971 (0.848) ↓ 0.010
Genus
 Butyricimonas 0.072 (0.029) 0.187 (0.046) 0.288 (0.081) 0.079 (0.023) + 0.217 (0.094) − 0.109 (0.032) ↓ 0.030
 Parabacteroides 0.488 (0.152) 0.735 (0.11) 1.293 (0.35) 0.579 (0.11) + 0.805 (0.255) − 0.155 (0.084) ↓ 0.023
 Streptococcus 0.06 (0.041) 0.129 (0.045) 0.097 (0.056) 0.003 (0.003) + 0.037 (0.015) − 0.125 (0.043) ↓ 0.023
 Christensenella 0.058 (0.019) 0.041 (0.015) 0.094 (0.027) 0.033 (0.005) + 0.037 (0.009) − 0.007 (0.01) ↓ 0.033
 Clostridium XIII IS UC 0.012 (0.012) 0.008 (0.008) 0.023 (0.006) 0.212 (0.052) + 0.013 (0.016) + 0.204 (0.045) ↑ 0.016
 Flavonifractor 0.085 (0.017) 0.079 (0.004) 0.282 (0.032) 0.082 (0.006) + 0.197 (0.046) + 0.003 (0.008) ↓ 0.047
 Sutterella 0.451 (0.046) 0.832 (0.302) 5.304 (1.0) 1.569 (0.471) + 4.85 (0.989) + 0.737 (0.772) ↓ 0.030
 Cronobacter 0 (0) 0.003 (0.003) 0.116 (0.023) 0.02 (0.016) + 0.116 (0.023) + 0.017 (0.012) ↓ 0.019
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iso-valeric acid, nor total branched SCFA and between CE 
and cellulose at any time point.
When compared to FOS, CE fermentation produced sig-
nificantly lower levels of acetic acid after 5 (p = 0.013) and 
10 h (p = 0.021) of fermentation with no significant differ-
ence observed between CE and FOS after 24, 36 and 48 h 
of fermentation. Butyric acid concentrations were signifi-
cantly lower with CE fermentation after 5 (p = 0.002), 10 
(p = 0.017) and 24 (p = 0.042) hours compared to FOS, but 
no significant difference was noted after 36 and 48 h of fer-
mentation. Total SCFA concentrations were significantly 
lower after 5, 10, 24 and 36 h with CE compared to FOS, 
yet total SCFA concentrations were similar after 48 h of 
fermentation. Propionic acid, iso-butyric acid, valeric acid, 
iso-valeric acid and hexanoic acid concentrations with CE 
treatment were similar to FOS over all time points assessed, 
with no significant differences noted.
Depolymerized extract (DE) (Table 4)
Within 5 h of fermentation of the DE extract, the concen-
tration of propionic acid was significantly higher than in 
cellulose vessels (p = 0.004) and the concentration of pro-
pionic acid was significantly higher compared to cellulose 
for all the subsequent time points. Propionic acid concen-
trations were similar to FOS at all time points. The con-
centrations of acetic acid, propionic acid, butyric acid, and 
Table 4  Fatty acid 
concentrations produced during 
batch culture fermentations
A table listing the concentrations of short-chain fatty acids in the effluent of batch culture vessels after 
incubation with cellulose, FOS, CE and DE after 5, 10, 24. 36 and 48 h. Samples were taken at the vari-
ous time points, centrifuged, and the SCFA were quantified using a GC-FID. Significant differences in the 
individual SCFA, total SFCA and total BCFA between cellulose and each treatment (FOS, DE, CE) at each 
time point was determined using an independent t test. *p < 0.05 (n = 3)
Cellulose FOS CE DE
Mean SEM Mean SEM P value Mean SEM P value Mean SEM P value
Acetic acid
 5 11.89 1.195 39.41 4.810 0.005 16.80 2.253 0.126 19.55 3.386 0.100
 10 16.10 1.068 45.95 4.080 0.002 30.35 1.183 0.001 42.10 5.413 0.036
 24 17.95 0.101 51.36 4.492 0.002 39.71 2.122 0.009 48.65 2.538 0.007
 36 19.48 0.581 53.70 4.762 0.002 45.49 1.929 0.000 57.62 8.973 0.013
 48 20.12 0.596 55.88 4.512 0.001 54.11 11.674 0.044 54.32 3.772 0.001
Propanoic acid
 5 2.75 0.196 11.06 2.632 0.035 4.53 0.177 0.003 6.06 0.509 0.004
 10 3.63 0.228 15.13 3.087 0.021 10.68 1.382 0.007 17.89 2.303 0.004
 24 4.49 0.317 17.25 2.970 0.013 15.49 1.852 0.004 20.69 1.984 0.001
 36 5.11 0.149 18.26 3.107 0.013 17.80 1.326 0.010 24.39 3.999 0.009
 48 5.42 0.287 19.33 3.525 0.017 21.59 5.527 0.043 23.02 2.104 0.001
Butyric acid
 5 3.37 0.109 13.09 0.565 0.000 5.43 0.829 0.070 5.09 0.755 0.089
 10 4.89 0.236 22.25 2.144 0.001 11.04 1.868 0.031 9.80 1.628 0.041
 24 6.65 0.148 26.44 2.867 0.002 16.01 2.090 0.011 12.42 1.467 0.017
 36 7.78 0.229 28.67 2.982 0.002 19.33 2.760 0.014 15.10 1.721 0.049
 48 8.50 0.195 30.69 3.036 0.002 22.92 0.702 0.000 15.18 1.851 0.023
Total SCFA
 5 18.98 1.515 63.92 2.837 0.000 27.84 3.692 0.091 32.62 5.960 0.091
 10 26.62 1.500 84.88 1.544 0.000 56.14 3.701 0.002 72.99 10.163 0.011
 24 32.76 1.118 98.69 0.873 0.000 75.76 1.271 0.000 88.18 8.139 0.009
 36 36.84 1.638 105.56 1.450 0.000 89.46 3.577 0.000 104.72 16.786 0.016
 48 39.13 1.366 112.04 2.861 0.000 107.79 17.710 0.018 99.98 6.970 0.001
BCFA
 5 0.99 0.347 0.44 0.239 0.260 0.96 0.505 0.967 1.53 1.022 0.645
 10 1.93 0.362 1.43 0.659 0.539 3.80 2.699 0.531 2.52 1.381 0.703
 24 3.31 0.754 2.98 0.840 0.781 3.64 0.745 0.774 5.05 2.785 0.602
 36 4.05 0.737 4.07 0.857 0.988 5.24 0.987 0.389 6.29 2.395 0.424
 48 4.65 0.596 5.14 0.765 0.639 7.37 0.951 0.072 6.32 1.464 0.350
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total SCFA were significantly higher with DE treatment 
compared to cellulose after 10 h and for all subsequent 
time points. The acetate:propionate ratio was shown to 
be significantly lower than the cellulose control following 
10, 24, 36 and 48 h (p < 0.05) (Fig. 5). There were no sig-
nificant differences in the concentration of total branched 
SCFA, the individual branched-chain SCFAs iso-butyric 
acid and iso-valeric acid or valeric acid and hexanoic 
acid SCFAs between CE and cellulose at any time point. 
Compared to FOS, acetic acid and total SCFA concentra-
tions were significantly lower after 5 h of fermentation 
(p = 0.028 and p = 0.009, respectively), but not after 10, 
24, 36 and 48 h of DE fermentation. Butyric acid concen-
trations were significantly lower compared to FOS for all 
the time points assessed.
Fructooligosaccharides (FOS) (Table 4)
Within 5 h of incubation, FOS was observed to significantly 
increase the concentration of acetic acid (p = 0.005), pro-
pionic acid (p = 0.035), butyric acid (p < 0.001), and total 
SCFA (p < 0.001) compared to cellulose. The concentra-
tions were significantly higher for all subsequent time points. 
There was no difference in branched-chain SCFA with FOS 
fermentation compared to cellulose.
Discussion
This study has provided clear indications that crude and 
depolymerized non-digestible components of L. digi-
tata (CE and DE) are fermented by human fecal bacterial 
Fig. 5  The effects of 1% (w/v) cellulose (Cell), fructooligosaccha-
rides (FOS), crude polysaccharide-rich extract (CE); and depolymer-
ized crude polysaccharide-rich extract (DE), on the acetate to propi-
onate ratio of batch culture fermentate after 5 (a), 10 (b), 24 (c), 36 
(d) and 48 (e) h of incubation under anaerobic conditions at 37 °C. 
SCFA concentrations of each supernatant were assessed using a GC-
FID. Significant differences in the acetate to propionate ratio between 
cellulose and each treatment (FOS, DE, CE) at each time point were 
determined using an independent t test. *p < 0.05 (n = 3)
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populations. This was evidenced by significant increases in 
acetate, butyrate and total short-chain fatty acids after 10-h 
fermentation with CE, as well as DE compared to cellulose 
(Table 4), and was shown to continue for the majority of the 
remaining incubation time in the experiment. The culture-
dependent microbial analysis showed that neither CE nor DE 
stimulated Lactobacilli or Bifidobacteria populations. The 
culture-independent sequencing of the 16S region revealed 
a number of changes at the family and genus level when 
compared to cellulose, including the stimulation of Parabac-
teroides, Dialister and Lachnospiraceae populations, each 
of which have been shown to be reduced in IBD-associated 
dysbiosis, with Lachnospiraceae also suggested to be protec-
tive against colon cancer [40–42].
The ability of the microbiota to utilize the seaweed fiber 
components as an energy source is primarily dictated by 
the presence of enzymes which can hydrolyze the various 
glycosidic bonds throughout the fiber structure [43]. There 
are numerous in vitro human fecal batch culture experi-
ments previously carried out on each individual seaweed 
fiber (alginate/laminarin/fucoidan), and these studies have 
demonstrated that both alginate and laminarin fibers can 
be efficiently fermented by the human microbiota [24, 25, 
31–35, 44, 45]. These observations are supported by previ-
ous reports that Bacteroides species from the human micro-
biota possess the hydrolytic enzymes, β-glucanase and algi-
nate lyase, which are able to breakdown the linkages that 
make up laminarin and alginate, respectively, and have been 
noted in both Asian and Western populations [31, 46–48]. 
There is evidence from a murine study to show that fucoidan 
can also modulate the composition and metabolic activity 
of the gut microbiota. Dietary supplementation of a 50-kDa 
fucoidan fraction in combination with the chemotherapeutic 
drug associated with gut mucosal damage, cyclophospha-
mide was found to increase Coprococcus, Rikenella, and 
Butyricicoccus species and increase total SCFA, propionate 
and butyrate concentrations in feces. Whether the effects 
on gut microbiota composition and metabolic activity are 
through fucoidan fermentation or through protection against 
mucosal damage from cyclophosphamide supplementation 
remains to be elucidated. The degradation of polysaccha-
rides by the microbiota can ultimately lead to metabolism/
cross metabolism of the released monomers to produce a 
range of microbial products, including short-chain fatty 
acids amongst others [49]. The failure to degrade fucoidan 
may limit its potential impact on the microbiota and thus 
any noted changes would be independent of its catabolism 
and fermentation.
The current study undertaken did not characterize the 
polysaccharide structural composition of either CE or DE; 
however, the increasing SCFA production following incu-
bation with the human fecal matter in the fermenter would 
suggest that bacteria present in the human microbiota 
possess the enzymes capable of degrading at least some of 
the complex polysaccharides present in the seaweed extract. 
The fermentation of both the extracts resulted in significant 
increases in propionic acid compared to cellulose and both 
the extracts were similar to the prebiotic FOS with respect 
to propionic acid production after 5 h of fermentation and 
for all subsequent time points. Acetic acid, butyric acid, and 
total SCFA concentrations were significantly higher with 
both CE and DE compared to cellulose after 10 h of fer-
mentation. CE fermentation resulted in similar amounts of 
acetic acid and butyric acid as FOS after 24 and 36 h of 
fermentation, respectively, and for subsequent time points. 
DE fermentation resulted in increases in acetic acid and total 
SCFA which were comparable with those produced by FOS 
after 10 h of fermentation and for all subsequent time points. 
Both extracts were shown to significantly reduce the acetate 
to propionate ratio after 24 h, which persisted for the remain-
der of the experiment. This could hold significance in light 
of recent research that has implicated a reduced acetate to 
propionate ratio with lipogenesis [50, 51], as well as emerg-
ing evidence to implicate a role for colonic propionate in the 
prevention of weight gain in overweight adult humans [52].
The fermentation patterns noted in the current study are 
comparable to previous studies that have investigated the 
fermentability of individual seaweed polysaccharides in both 
in vitro human fecal fermentation experiments and in vivo 
animal models [24, 25, 31–35, 44] and demonstrated that 
brown seaweed-derived polysaccharides increased the pro-
duction of acetic acid, propionic acid, butyric acid as well 
as total SCFA. The crude polysaccharide extracts (CE, DE) 
used in the current study exhibited a lag effect, with the 
production of most of the SCFA occurring after 10 h and 
not 5 h. This lag effect has previously been reported with 
alginate [44], which is known to be a major polysaccha-
ride component present in L. digitata [53]. This lag effect 
of fermentation may be attributed to the adaption of the 
fecal bacterial species to a novel carbon source [54]. The 
higher production of propionate noted during DE fermenta-
tion compared to CE after 5 h is likely owing to the lower 
molecular weight polysaccharides (> 1 kDa), with alginate 
a probable candidate [31, 34, 44]. The CE treatment had 
significantly higher concentrations of butyrate after 48 h 
of fermentation compared to DE, suggesting a more sus-
tained, slower fermentation profile which would be expected 
with more complex, higher molecular weight polysaccha-
rides [55]. Previous batch fermentation studies have dem-
onstrated that laminarin and alginate individually increase 
SCFA concentrations during batch culture fermentations 
whilst fucoidan would appear to have limited impact [24, 
44]. Furthermore, the fermentation properties of the com-
plete fiber component of late-season-harvested L. digitata 
have been assessed with human fecal fermentation experi-
ments [24, 25]. The first study [24] found that L. digitata 
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fiber fermentation appeared to alter individual SCFA ratios 
as well as increase total SCFA concentrations with a similar 
lag period noted in this study. While the second study [25] 
did not assess effects on SCFA, the authors observed that 
laminarin was fermented after a 24-h incubation. Collec-
tively, it is likely that the fermentation of both alginate and 
laminarin is contributing to the potential prebiotic effect of 
increasing both butyrate and propionate production observed 
in the current study.
Neither the CE nor DE extract stimulated cultivable Lac-
tobacillus or Bifidobacteria species, and this lack of effect 
was also reported in a study by Deville et al. [25]. In con-
trast, others have found a stimulating effect with alginate 
oligosaccharides on Lactobacillus and Bifidobacteria, both 
with in vitro human fecal fermentations and when fed to 
rats [56]. The size-exclusion filtration carried out on the 
extract used in this study may have removed these oligosac-
charides (< 1 kDa) and thus could explain the lack of effect 
seen in this study. In the current study, FOS treatment was 
observed to significantly increase cultivable Bifidobacteria 
but not Lactobacillus, whereas another study has reported 
that Lactobacillus and not Bifidobacteria populations were 
increased with FOS [25]. The lack of consistency in the 
effects of certain fibers to stimulate specific bacterial genera 
from in vitro studies may be attributable, in part, to the lim-
ited study power owing to variability of the fecal microbial 
composition of the donors and highlights the problematic 
issues of using such models to investigate dietary-mediated 
changes to GM structure and composition.
Results from the 16S rRNA pyrosequencing identified 
that both the CE and DE extracts impacted mainly within 
the two dominant phyla, Bacteroidetes and Firmicutes. As 
previously discussed, the Bacteroidetes species have con-
siderable metabolic plasticity owing to an extensive array 
of Carbohydrate-Active Enzymes (CAZymes) including sea-
weed-glycan-degrading enzymes [31, 57], which allow them 
to catabolize the wide range of polysaccharides present in 
the human diet. Therefore, it is not surprising that the poly-
saccharide-rich seaweed extracts were found to significantly 
increase genera belonging to this phylum. The ability of both 
extracts to significantly increase the relative abundance of 
bacteria from the genus Parabacteroides was also observed 
in another study in which laminarin was fed to rats [30]. The 
authors noted that the species Parabacteroides distasonis 
was only detected in the laminarin-supplemented rats and 
not alginate-supplemented or control-fed rats. This finding 
would strongly suggest that the Parabacteroides stimulat-
ing effect noted in the current study is likely to be attribut-
able to laminarin. A recent study highlighted the potential 
immunomodulatory effect of Parabacteroides distasonis in 
DSS-induced colitis in mice [58], albeit more evidence to 
support its possible impact on health in humans is required. 
Lachnospiraceae were also found to be stimulated with both 
CE and DE extracts. Lachnospiraceae are well represented 
in the human gut microbiome and are known to degrade non-
digestible plant polysaccharides from the diet into SCFAs 
such as acetate, propionate and butyrate [59, 60]. The 
increase in SCFA production observed with the extracts in 
this study could, in part, be attributed to bacteria belonging 
to this family. The observed depletion of Lachnospiraceae 
members in colon cancer has led to speculation that some 
of its members may confer protection against colon cancer 
through the production of butyrate, which is known to exert 
a range of anticancer activities [61]. The stimulating effect 
of DE on bacteria from the Dialister genus was also found 
to be inversely associated with IL-6 in humans who were 
fed a fiber-rich diet from whole grains [62]; however, some 
reductions in Dialister species have been reported in colon 
cancer and Crohn’s disease [63, 64].
The extracts in the current study were subjected to a 
simulated in vitro digestion followed by size-exclusion 
chromatography with a molecular weight cutoff of 1 kDa 
prior to use in the colon model. The simulated digestion 
used in the current study provided indications that diges-
tion-resistant polysaccharides present within the CE and 
DE extract had the potential to be extensively fermented 
by the human microbiota, which corroborates previous 
studies which have demonstrated that isolated laminarin, 
fucoidan and alginate are resistant to simulated gastroin-
testinal digestion [45]. However, whilst the dialysis step 
in the simulated digestion removes contents unlikely to be 
available in the colon, it may also remove colon-available 
non-digestible low molecular weight oligosaccharides 
such as those derived from alginate and laminarin. This 
presents an additional limitation to this in vitro study.
Conclusions
In conclusion, this study provides evidence that polysac-
charide-rich extracts from L. digitata are both resistant to 
human digestive enzymes and are fermentable by human 
fecal bacterial populations. The demonstration that both 
extracts altered the metabolic activity of human fecal micro-
bial populations in a way which might confer health benefits 
illustrates the potential of this seaweed extract to improve 
health and well-being. Further work is warranted to assess 
whether these changes in both bacterial composition and 
metabolic activity occur in vivo, and critically, whether such 
changes can confer health benefits to the host to clarify the 
potential of L. digitata as a source material for the crude 
extraction of fermentable polysaccharide fibers as a func-
tional food ingredient.
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